Effects of secukinumab on metabolic and liver parameters in plaque psoriasis patients.

J Eur Acad Dermatol Venereol · 2020 · PMC7065121 · PMID 31599476

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

2 a), a diagnostic criterion for diabetes according to current guidelines, 34 secukinumab treatment showed a trend towards lowering FPG levels compared with placebo treatment during the first 12 weeks.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.